coronavirus vaccine Covaxin began its phase-three human clinical trial at AIIMS in New Delhi on Thursday with Dr M V Padma Srivastava, the chief of Neurosciences Centre at the premier institute, and three other volunteers receiving the first dose.AIIMS' Dr Srivastava was the first one to receive the shot, which would be given to around 15,000 volunteers at the medical institute over the next few days, reports news agency PTI.The first dose of 0.5 ml intramuscular injection was given to four volunteers.
They were under observation for two hours and will be monitored for the next few days, the report said.Dr Srivastava said, "Covaxin is the first indigenously-developed anti-coronavirus vaccine and on top of that, my institute is participating.